Compare FirstEnergy Corp. (FE) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FirstEnergy Corp. vs Zimmer Biomet Holdings Inc — how do they compare? FirstEnergy Corp. trades at $45.15 (market cap $25.95B), while Zimmer Biomet Holdings Inc trades at $89.6 (market cap $16.95B). The key difference: FirstEnergy Corp. is the larger of the two by market cap, and FirstEnergy Corp. pays the higher dividend (4.15%). Which is the better fit depends on your goals — on Pluang, investors hold FirstEnergy Corp. for 71 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| FE | ZBH | |
|---|---|---|
Market Cap | $25.95B | $16.95B |
Volume | 5,643,833 | 2,505,240 |
Sector | Utilities | Health |
52-Week High | $51.91 | $103.98 |
52-Week Low | $43.04 | $79.58 |
Typical Hold Time | 71 Days | 89 Days |
Enterprise Value | $54.87B | $24.02B |
Dividend Yield | 4.15% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FirstEnergy (FE) trades at $44.93, up 0.79% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported Q2 2026 EPS of $0.50, slightly missing expectations, while Q1 beat estimates. Revenue grew to $15.09B in 2025 with a 6.86% net margin. Analysts maintain a Moderate Buy rating with a $52.80 price target, representing 17.5% upside. Recent news highlights the $36B Energize365 investment plan and consistent dividend payments.
FirstEnergy presents a stable utility investment with steady revenue growth and dividend yield, though elevated debt levels and inconsistent earnings performance pose risks. The stock's current valuation at 23.98 P/E appears reasonable given the utility sector's defensive characteristics. Upside potential exists if the company can consistently meet earnings expectations and execute its capital investment program effectively.
Zimmer Biomet (ZBH) trades at $88.70, up 0.24% on the day, with a bearish technical outlook but strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.07 exceeding expectations. Revenue growth remains steady, reaching $8.23B in 2025, while profitability metrics like a 69.87% gross margin and 9.48% net margin reflect operational efficiency. Recent corporate news includes a $0.24 quarterly dividend declaration and leadership promotions aimed at accelerating commercial transformation.
The investment outlook is mixed, with analyst consensus leaning hold (52.38%) but a price target of $103.11 suggesting 16% upside. Key opportunities include sustained earnings beats and strategic initiatives, while risks involve rising debt levels, competitive pressures, and technical bearish signals. The stock's current valuation at a P/E of 21.57 appears reasonable relative to growth prospects, but investors should weigh fundamental strength against near-term technical weakness and macroeconomic headwinds in the healthcare sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
